Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).

Per Damkier

doi:10.22541/au.158465422.20540674

loading page

Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).

Per Damkier

18 Mar 2020Submitted to BJOG: An International Journal of Obstetrics and Gynaecology

Show details

Hide details

19 Mar 2020Submission Checks Completed

19 Mar 2020Assigned to Editor

27 Mar 2020Reviewer(s) Assigned

13 Apr 2020Review(s) Completed, Editorial Evaluation Pending

28 Apr 2020Editorial Decision: Revise Major

Peer review status:IN REVISION